Connor, Clark & Lunn Investment Management (CC&L)
BVS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Bioventus BVS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,354
Closed -$739K – 1567
2025
Q4 		$739K Sell
99,354
-27,444
-22% -$197K ﹤0.01% 1220
2025
Q3 		$848K Sell
126,798
-48,725
-28% -$338K ﹤0.01% 1111
2025
Q2 		$1.16M Sell
175,523
-25,606
-13% -$182K ﹤0.01% 1005
2025
Q1 		$1.84M Buy
201,129
+4,950
+3% +$49.4K 0.01% 757
2024
Q4 		$2.06M Sell
196,179
-62,577
-24% -$740K 0.01% 716
2024
Q3 		$3.09M Buy
+258,756
New +$2.24M 0.02% 559

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BVS Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Bioventus (BVS) in Q1 2026, closing a stake of 99,354 shares — an estimated $739K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BVS in Q3 2024 and held it in 6 quarters. The position peaked at $3.09M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 99,354 Bioventus shares in Q1 2026, an estimated $739K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Bioventus in Q3 2024 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Bioventus position peaked at $3.09M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.